Usage Rights: All content is available for editorial use with attribution to The Ohio State University Wexner Medical Center.
A critical medical advancement from researchers at The Ohio State University Wexner Medical Center addresses the rising threat of leishmaniasis, a neglected tropical disease now infiltrating the United States. Historically contained to tropical regions, this parasitic infection, which can lead to severe skin ulcers and organ failure, is increasingly appearing in border states, creating a significant public health challenge for which many U.S. physicians remain unprepared.
To combat this growing crisis, the research team has pioneered a dual-pronged approach:
- The First-Ever Vaccine: Led by Dr. Abhay Satoskar, the team developed a vaccine that achieved 100% efficacy in animal models, with human trials slated to begin later this year.
- Essential Diagnostic Tools: Researchers are launching a specialized skin test, a critical component requested by the World Health Organization (WHO) for global disease surveillance and vaccine assessment.
- Public Health Strategy: As the disease establishes potential reservoirs in domestic canine populations, this initiative provides a scalable defense against an often-overlooked pathogen.
As leishmaniasis migrates, this research from The Ohio State University Wexner Medical Center offers a necessary, evidence-based solution. Editors looking to cover this significant public health story can access broadcast-quality video and multimedia assets to support their reporting.
